ArticleJournal of contemporary brachytherapy2016

Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer.

Peter W Henderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.